About the Role
We are seeking a highly motivated, detail-oriented Deputy Editor with a PhD and research expertise in medicinal chemistry, chemical biology, or biocatalysis to join our in-house editorial team across Chemistry – A European Journal and ChemBioChem.
This is an exciting opportunity to contribute to the strategic development and editorial direction of two established chemistry journals, with a particular focus on medicinal chemistry, chemical biology and related research. You will play a key role in ensuring the quality, integrity and impact of published content, while working closely with authors, reviewers and fellow editors.
This position is a fixed-term parental leave cover, with an anticipated end date of 25 January 2028.
How you will make an impact
•Identify emerging research trends in medicinal chemistry, chemical biology and biocatalysis, and commission high-impact content.
•Collaborate with the Editor-in-Chief and editorial board to shape journal strategy, scope and development.
•Represent Chemistry – A European Journal and ChemBioChem at scientific conferences and within the international research community.
•Contribute to initiatives that promote sound science, transparency and ethical publishing practices.
•Manage the peer review process for submitted manuscripts, ensuring timely and rigorous evaluation.
•Make editorial decisions and provide constructive feedback to authors.
We are looking for people who have/are
•A PhD in Medicinal Chemistry, Chemical Biology, Biocatalysis or a closely related discipline, with a research focus in one or more of these areas, is a strict requirement.
•A strong publication record and understanding of the research landscape in medicinal chemistry, chemical biology or biocatalysis.
•Prior editorial experience (e.g. as a reviewer, guest editor or editorial board member) and an understanding of Open Access workflows and Open Research is highly desirable, but not essential.
•Excellent communication and organisational skills, with an interest in scientific publishing and a commitment to editorial excellence.
